HCX Pharmaceuticals LLP

This is for informational purposes only. For medical advice or diagnosis, consult a professional.

Rabies Human Monoclonal Antibody (RMAb)

Product Introduction

Rabies Human Monoclonal Antibody (RMAb), also known as Rabishield, is a revolutionary treatment for post-exposure prophylaxis (PEP) of rabies. It is a type of passive immunization that provides immediate protection against the rabies virus.

Uses

RMAb is used in the treatment of individuals who have been exposed to the rabies virus through a bite or scratch from an infected animal. It is administered as part of a PEP regimen, which may also include rabies vaccination.

Benefits of RMAb

• Immediate Protection: RMAb provides immediate protection against the rabies virus, which is crucial in preventing the virus from reaching the central nervous system.
• Enhanced Efficacy: RMAb is more potent and requires a lower dose than traditional rabies immune globulin (RIG), making it a more cost-effective treatment option.
• Improved Patient Comfort: RMAb is administered intramuscularly, which is less painful than the intradermal administration of RIG.

Side Effects of RMAb

Side effects of RMAb are generally mild and may include:

• Local Reactions: Pain, redness, or swelling at the injection site.
• Systemic Reactions: Fatigue, headache, or muscle aches.

How to Use

RMAb is administered intramuscularly as soon as possible after exposure to the rabies virus. The specific dosage and administration schedule will be determined by a healthcare professional.

How it Works

RMAb works by binding to the rabies virus and neutralizing it, preventing it from infecting cells. This immediate protection allows the body's immune system time to develop its own antibodies against the virus.

Safety Advice

• Consult Your Doctor: If you have been exposed to the rabies virus, seek medical attention immediately.
• Allergic Reactions: Inform your doctor about any allergies or medical conditions before receiving RMAb.
• Pregnancy and Breastfeeding: Pregnant and breastfeeding women can receive RMAb.

RMAb is a significant advancement in the treatment of rabies. By providing immediate protection against the virus, it can help save lives and prevent the devastating consequences of rabies infection.